At Daykin Molecular Systems, we are a team of scientists and entrepreneurs working to bring lifesaving RNA driven therapeutics to people around the world. Our work is focused on solving one of the biggest practical limits in RNA medicine: cold chain dependence.  mRNA therapies and vaccines today are constrained by freezing, shipping, and storage. Our work changes that. We’ve developed and patented a stabilizing solution - built entirely from FDA-approved components - that keeps mRNA and DNA formulations stable at ambient temperature for over 30 days, and even at 40 °C, without loss of function.  When RNA can travel and perform at room temperature, everything changes. Development, manufacturing, and distribution of innovative medicines becomes faster and less expensive.  And even more importantly, therapies can finally reach places that freezers never could, impacting the lives of more and more people around the globe.

Daykin Molecular Systems

Org chart

Teams

Offices